Long‐Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2‐Targeted Therapy

BACKGROUND. An increasing proportion of human epidermal growth receptor 2 (HER2) positive (HER2+) metastatic breast cancer (MBC) is diagnosed as de novo stage IV disease. We hypothesize that a subset of these patients who achieve no evidence of disease (NED) status after multimodality HER2‐targeted...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Wong, Yao, Raghavendra, Akshara Singareeka, Hatzis, Christos, Irizarry, Javier Perez, Vega, Teresita, Horowitz, Nina, Barcenas, Carlos H., Chavez‐MacGregor, Mariana, Valero, Vicente, Tripathy, Debu, Pusztai, Lajos, Murthy, Rashmi K.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2018
Assuntos:
Breast Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6519755/
https://ncbi.nlm.nih.gov/pubmed/30139836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0213
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados